PL

Prem Lata Mago

Director Director DIN 06782216
DIN 06782216 First appointment Jan 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2014
Shareholding value Locked Premium profile

About Prem Lata Mago

Data last updated:

Prem Lata Mago has 12 years in corporate governance. Formerly with 1 company, such as Standard Pharmaceuticals Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 06782216
Primary Designation Director
First Appointment 15 Jan 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Standard Pharmaceuticals Ltd U24232WB1995PLC075698
Director15 Jan 20141995Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Standard Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Prem Lata Mago

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prem Lata Mago

Prem Lata Mago has 12 years in corporate governance. Formerly with 1 company, such as Standard Pharmaceuticals Ltd. Engaged in General Business. Contributes to corporate operations.

Prem Lata Mago is associated with 0 companies as a director.

Prem Lata Mago has expertise in General Business.

Prem Lata Mago has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available